Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketek versus amoxicillin for recurrent Lyme disease
ISRCTN03563617Phase 2Completed
- Sponsor
- First Medical Associates
- Start
- Sep 2005
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Lyme borreliosis comparing Ketek with Amoxicillin comparator (2 arms). Primary endpoint: Success using clinical impression. Started Sep 2005; status: completed.
02
Drugs
telithromycinamoxicillin
03
Conditions
Lyme borreliosis
Beyond the preview
Go deeper on ISRCTN03563617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN03563617.